Smith Stan
SEC Form 4 insider trading activity
Smith Stan has filed 7 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jun 2, 2026.
On the most recent filing, Smith Stan is listed as Director at MAIA Biotechnology, Inc. Inside the rolling window, Smith Stan reported 7 open-market purchases totaling $237K in MAIA and no open-market sales. The largest disclosed transaction in the window is a purchase of 75,000 MAIA shares on Jun 1, 2026, worth $100K.
Companies traded
Other insiders at MAIA
Insider Buying
$237K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 1, 2025 | MAIA | Purchase | $25K |
Frequently asked questions
How many SEC Form 4 filings has Smith Stan made?
Smith Stan has filed 7 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Smith Stan trade?
Smith Stan has filed SEC Form 4 disclosures for 1 company, including MAIA.
When was Smith Stan's most recent SEC Form 4 filing?
Smith Stan's most recent SEC Form 4 filing on Tracefour is dated Jun 2, 2026.
What is Smith Stan's total buy and sell value in the current window?
Inside the rolling retention window, Smith Stan bought $237K and sold $0 based on SEC Form 4 filings.
What was Smith Stan's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 75,000 MAIA shares on 2026-06-01, worth $100K, per SEC Form 4 filings.